Article
Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
Epilepsy research - 1 Dec 2013
Yun Wenting, Zhang Feng, Hu Cheng, Luo Xiaopei, Xue Peng, Wang Jing, Ge Yubin, Meng Hongmei, Guo Yingjie
Abstract excerpt
The pharmacokinetics and pharmacodynamics of carbamazepine (CBZ) vary widely among patients with epilepsy. In this study, we sought to investigate the effects of genetic polymorphisms of the microsomal epoxide hydrolase (EPHX1), the sodium channel α subunit type I (SCN1A) and the cytochrome P450 3A4 (CYP3A4) genes on plasma CBZ concentrations and pharmacoresistance in Chinese patients with epilepsy. The EPHX1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
